Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Jan 21;379(9812):196-8.
doi: 10.1016/S0140-6736(11)61845-X. Epub 2011 Dec 11.

β-agonists for ARDS: the dark side of adrenergic stimulation?

B Taylor Thompson  1
Affiliations
Comment

β-agonists for ARDS: the dark side of adrenergic stimulation?

B Taylor Thompson. Lancet. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Smith FG, Perkins GD, Gates S, et al. for the BALTI-2 study investigators Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet. 2011 doi: 10.1016/S0140-6736(11)61623-1. published online Dec 12. - DOI - PMC - PubMed
    1. Folkesson HG, Matthay MA. Alveolar epithelial ion and fluid transport: recent progress. Am J Respir Cell Mol Biol. 2006;35:10–19. - PMC - PubMed
    1. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163:1376–1383. - PubMed
    1. Perkins GD, McAuley DF, Thickett DR, Gao F. The β-agonist lung injury trial (BALTI): a randomised placebo-controlled clinical trial. Am J Respir Crit Care Med. 2006;173:281–287. - PubMed
    1. Grant AM, Altman DG, Babiker AB, et al. for the DAMOCLES study group Issues in data monitoring and interim analysis of trials. Health Technol Assess. 2005;9:1–235. - PubMed

MeSH terms

Substances